Antithrombotic and Antiplatelet Therapies

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

Side Branch Access

Techniques for achieving side branch access when anatomy is technically challenging.

By Khung Keong Yeo, MBBS, and Jason H. Rogers, MD

Utility of CT Coronary Angiography for Planning CTO Intervention

CTCA shows promise as an important modality in treating this challenging subset.

By Marc C. Newell, MD, and Robert S. Schwartz, MD

Guidelines for Antithrombotic and Antiplatelet Therapy for PCI

Do PCI guidelines address the current challenges?

By J. Emilio Exaire, MD, FACC, and Jorge F. Saucedo, MD

Antithrombotic Therapy for PCI

Alternatives that may surpass current UFH pathophysiology.

By Sean Javaheri, MD, and Sunil V. Rao, MD

Managing Patients After PCI

Combined dual-antiplatelet and anticoagulant therapy after PCI in patients with an indication for warfarin.

By Aslan T. Turer, MD, and J. Kevin Harrison, MD

The Scope of Stent Thrombosis

An analysis of the importance and occurrence of stent thrombosis.

By Leif Thuesen, MD

Understanding Resistance to Thienopyridine Antiplatelet Therapy

Targeting the antiplatelet effect with platelet function testing is a novel therapeutic approach that requires investigation.

By Matthew J. Price, MD

An Interview With Joseph Babb, MD

Dr. Babb discusses the development of the East Carolina Heart Institute, the importance of fellowship-in-training programs, and future challenges in interventional cardiology.

By Joseph Babb, MD